Physician profile
James Overmeyer
NPI 1295732089
$2,623.17
in general payments reported to CMS, 2019-2025
11 companies · $131 in 2025
The $131 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2020: $298 · 2021: $887 · 2022: $64.20 · 2023: $632 · 2024: $359 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,122.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $1,134.56 | 2021-2025 | Indigo System, Ruby Coil |
| Inari Medical, INC. | $450.50 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $385.49 | 2019-2023 | Embold Fibered |
| Stryker Corporation | $165.86 | 2023-2024 | Spinejack, Augment Injectable |
| Medtronic, INC. | $145.14 | 2022-2024 | Concertotm, Abre |
| Btg International INC. | $141.79 | 2019 | |
| Bard Peripheral Vascular, INC. | $101.80 | 2020-2021 | |
| Ethicon US, LLC | $39.96 | 2019 | |
| Cardiva Medical, INC. | $26.47 | 2020 | |
| Medtronic Vascular, INC. | $16.50 | 2019 | |
| Angiodynamics, INC. | $15.10 | 2023 | Navylist |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Overmeyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.